Entries by nextphas_verde

Reknown doctor to Lead Verde Science’s Huntington Disease Study

LAS VEGAS, Oct. 19, 2015 (GLOBE NEWSWIRE) — (VRCI) Verde Science, Inc., is a leading Pharmaceutical Research and Development Company that maintains a strong collaboration with leading scientists and pharma companies to create and test pharmaceutical formulations for optimal dosage and delivery mechanisms. Verde Science is pleased to announce that a known doctor has joined Verde […]

Verde Science to Sponsor/Present at the Huntington Study Group Annual Conference

LAS VEGAS, NV / ACCESSWIRE / October 12, 2015 / (OTCQB:VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabis-based prescription medicines to meet patients’ needs for a wide range of medical conditions, is pleased to announce it will be sponsoring and presenting at the twenty-third annual Huntington […]

Verde Science Announces Plan to Study Cannabis Preparation for Treatment of Huntingdon’s Disease

LAS VEGAS, Oct. 9, 2015 (Globe Newswire) – Verde Science, Inc. (VRCI), a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients’ needs for a wide range of medical conditions, is pleased to announce that along with some renowned research scientists it intends to study the […]

Verde Science Appoints International Banker Manfred A. Schauer

Las Vegas NV / May 20, 2015 / (VRCI-OTCQB) Verde Science Inc., a pharmaceutical research and development company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the appointment of Manfred Schauer as head of the Asia Pacific Region. Mr. Schauer is […]

Verde Science Adds Lawyer, Bradley J. Dixon, J.D. to the Board of Directors

Las Vegas NV / May 20, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing effective treatments for contemporary health issues, with an initial focus on developing cannabinoid-based prescription medicines is pleased to announce the appointment of Bradley J. Dixon, J.D. to its Board of Directors. Mr. Dixon is a partner with the […]

Verde Science Appoints New Chief Financial Officer with Pharmaceutical Sector Experience

Las Vegas NV / May 12, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients’ needs for a wide range of medical conditions is pleased to announce the appointment of David Alexander, CA as its new CFO, effective immediately. David graduated with BComm […]

Verde Science Adds Shantesh Hede, Ph.D. as Director of Product Development

Las Vegas NV / April 10, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the addition of Shantesh Hede, Ph.D. as Director of Product Development. Dr. Hede will be […]

Verde Science Signs Research and Development Pact with Institute of Chemical Technology

Las Vegas NV / April 8, 2015 / (VRCI-OTCQB) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the execution of a definitive Research and Development Agreement with the Institute of Chemical Technology […]

Verde Science Provides an Investor Update for Shareholders and Investors

Las Vegas NV / March 13, 2015 / Verde Science, Inc., (VRCI-OTCQB) a Medical Research and Development Company focused on developing effective treatments for emerging and contemporary health issues, with an initial focus on Medical Marijuana is pleased to update shareholders and investors regarding significant developments in the Medical Marijuana R&D arena. Verde Science has firmly established […]